PTPRC and cancer: More work is needed to integrate the contributions of CD45 exclusion, TCR allostery, auto-costimulation and signal termination to quantitative aspects of discrimination in the context of boosting natural T cell activation and T cell engineering to cope with challenges of infection, cancer and autoimmunity.